SCHEMBL5368632

SCHEMBL5368632

Cc1ccc(OB(Oc2ccc(C)c(Cl)c2)OC(C)(C)c2ccccn2)cc1Cl

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.36
DRD4 P21917 1/20 0.36
DRD3 P35462 1/20 0.36
NPC1 O15118 4/20 0.34
RAB9A P51151 4/20 0.34
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34
PKM P14618 1/20 0.34
TSHR P16473 1/20 0.34
KDM4E B2RXH2 1/20 0.34
AHR P35869 1/20 0.32
L3MBTL1 Q9Y468 2/20 0.31
ALDH1A1 P00352 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
SMN1; SMN2 Q16637 3/20 0.31
LMNA P02545 1/20 0.30
POLB P06746 1/20 0.30
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14503473 0.81 NPC1 (0.36) DRD2DRD4DRD3NPC1RAB9A
SCHEMBL5378926 0.73 KDM4E (0.44) DRD2DRD4DRD3NPC1RAB9A
SCHEMBL5377182 0.72 LMNA (0.38) DRD2DRD4DRD3NPC1RAB9A
SCHEMBL5368629 0.70 NPC1 (0.39) DRD2DRD4DRD3NPC1RAB9A
SCHEMBL2407527 0.70 KDM4E (0.44) DRD2DRD4DRD3NPC1RAB9A
SCHEMBL25955953 0.68 DRD1 (0.46) DRD2DRD4DRD3NPC1RAB9A
SCHEMBL29116273 0.68 DRD2 (0.43) DRD2DRD4DRD3NPC1RAB9A
SCHEMBL5373497 0.67 FFAR1 (0.37) DRD2DRD3NPC1RAB9AMEN1
SCHEMBL5373769 0.67 DRD2 (0.36) DRD2DRD4DRD3NPC1RAB9A
SCHEMBL5368720 0.66 DRD2 (0.34) DRD2DRD4DRD3NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259842-A1 Intracellular calcuim concentration increase inhibitors MIKOSHIBA, KATSUHIKO (JP) 2004-12-23 US claimed
EP-1444981-A1 INTRACELLULAR CALCIUM CONCENTRATION INCREASE INHIBITORS Mikoshiba, Katsuhiko (JP) 2004-08-11 EP claimed
US-7217701-B2 Intracellular calcium concentration increase inhibitors KATSUHIKO MIKOSHIBA (JP) 2007-05-15 US disclosed
US-20040259842-A1 Intracellular calcuim concentration increase inhibitors MIKOSHIBA, KATSUHIKO (JP) 2004-12-23 US disclosed
EP-1444981-A1 INTRACELLULAR CALCIUM CONCENTRATION INCREASE INHIBITORS Mikoshiba, Katsuhiko (JP) 2004-08-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259842-A1 Intracellular calcuim concentration increase inhibitors CAB39, BPGM, ORAI1 DRD2 4282/4885DRD4 4767/4885DRD3 4598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.